Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis. - Wikidata - awgldk - TriplyDB

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

http://www.wikidata.org/entity/Q34205956

about

Methionine Sulfoxide Reductase B3-Targeted In Utero Gene Therapy Rescues Hearing Function in a Mouse Model of Congenital Sensorineural Hearing Loss.Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies.Meconium ileus in cystic fibrosis is not linked to central repetitive region length variation in MUC1, MUC2, and MUC5AC.Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.The influence of genetics on cystic fibrosis phenotypes.Disease-modifying genes and monogenic disorders: experience in cystic fibrosis.Cystic fibrosis genetics: from molecular understanding to clinical application.Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene.Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse.The Functions of the Mammalian Methionine Sulfoxide Reductase System and Related Diseases

P2860

Q30359004-E4E249C7-C7BA-41BC-A64A-57F1BC753571 Q30608402-571EEB12-DAD4-4E8B-9D80-8BA08950D8A3 Q34617453-284B75BF-DF50-4E72-BC4B-DF7045CCBE21 Q35178642-0ED6DDC7-CD81-406D-B72C-47DB52D7D056 Q36526522-93F40876-0D27-4B3C-987B-2EC4B97AD3D6 Q38233032-F37DB9A1-02CA-4444-B901-BC8A0D4314BE Q38268916-DB8AE0CB-06FB-46AD-AFA5-25BEF91DE9B7 Q41659539-92827E8C-427E-4D64-B40B-0152CBD31DEE Q55396999-F2CE24B0-2F96-4B49-9AC7-3A2D89E3DD38 Q58723369-562C4542-715F-496B-B870-A15F76EF1AF7

P2860

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

http://www.wikidata.org/entity/Q34205956

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

@ast

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

@en

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

@nl

type

label

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

@ast

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

@en

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

@nl

prefLabel

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

@ast

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

@en

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

@nl

P1433

Q34205956-4FCF7799-4DB8-4C4D-9868-B0415B4EB483

P1476

Q34205956-33917B1F-C61C-48BD-A51F-B46FBCD0E82A

P2093

Q34205956-642FF779-A5C4-4977-BBF2-22CDE8705B73

Q34205956-6F6B0044-61D5-4F65-A1CB-8FAC93A4110F

Q34205956-7128E0B0-3137-4AB5-8D0D-B23B99545CEE

Q34205956-71931D8D-693C-4025-8D86-81C0A7EF507C

Q34205956-7F4782A7-F97B-406C-89D4-7ECF6FB8A2CA

Q34205956-7F63B5EF-2BCF-4F6D-9051-D540E49C3BD5

Q34205956-9B8074F3-7206-4132-BFE7-EA2804F9DBA5

Q34205956-EFA2C8B9-5752-4FB7-9D7F-8A05ACF0AF9F

Q34205956-F041CA70-7A99-4F64-97F8-A7EA0810DE07

P2860

Q34205956-01571C66-6946-471F-8F49-D8528A6F7494

Q34205956-03F25672-E92D-450E-AF66-DBF799BFEB71

Q34205956-19454CB4-2E53-44EE-A881-BD6084E4A9F0

Q34205956-1EA33012-3CC7-4C9A-A914-E7303DBDECF2

Q34205956-27849FFC-CFAA-44B3-A66E-A8BF6493B5CB

Q34205956-2947D80E-EA16-4E38-80D1-DFF8F2E98D95

Q34205956-294CABAB-B4C8-4424-AC82-3EB540EAD8BF

Q34205956-31446BA8-BF63-4379-8E1E-915B85C546CD

Q34205956-3B2E8461-FDEA-44E7-996D-4E69AC56B508

Q34205956-3B77CBF0-364B-40D6-AEDD-763574CC139D

P304

Q34205956-00318A15-3FA9-4AD2-9BCC-F0D7ADB3EF35

P31

Q34205956-0BEE5F7F-B288-4C05-AA33-F0BD2D175240

P356

Q34205956-CC548A16-B6F0-458B-8EBF-973C58D3CE7E

P433

Q34205956-2445B1BE-A893-4421-BBF1-09E70DDC2264

P478

Q34205956-ABACD0F5-D279-4444-808C-195BCD173647

P50

Q34205956-4068A0E6-16DD-449D-85EB-77E233A69C33

P577

Q34205956-988D56FB-7832-4423-AA9B-52ADF105EE1F

P5875

Q34205956-BAC8981F-2B4F-4A2B-B96D-F88748C9A4D5

P698

Q34205956-324D6FC7-F69A-42B0-86D0-C7877A7DC4AB

P921

Q34205956-8C16AF22-2D52-4524-98A6-E5A77737678F

P932

Q34205956-C6675CE1-8E69-4CA2-9E86-EE16C3DA7623

P356

JOURNAL.PGEN.1002580

P1433

P1476

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis

@en

P2093

Garry R Cutting

http://www.w3.org/2001/XMLSchema#string

Jackob Moskovitz

http://www.w3.org/2001/XMLSchema#string

Kathleen M Naughton

http://www.w3.org/2001/XMLSchema#string

Lindsay B Henderson

http://www.w3.org/2001/XMLSchema#string

Michael R Knowles

http://www.w3.org/2001/XMLSchema#string

Mitchell L Drumm

http://www.w3.org/2001/XMLSchema#string

Peter R Durie

http://www.w3.org/2001/XMLSchema#string

Rhonda G Pace

http://www.w3.org/2001/XMLSchema#string

Vishal K Doshi

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and functional expression of a human peptide methionine sulfoxide reductase (hMsrA)

Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues

Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.

Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10

Haploview: analysis and visualization of LD and haplotype maps

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

Pathophysiology of gene-targeted mouse models for cystic fibrosis

Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals

Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2.

Identification of the cystic fibrosis gene: genetic analysis

P304

e1002580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PGEN.1002580

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Scott M Blackman

P577

2012-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221967724

http://www.w3.org/2001/XMLSchema#string

P698

22438829

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

3305406

http://www.w3.org/2001/XMLSchema#string